Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedLocations section updated; Maryland, North Carolina, and Pennsylvania sites added and the HHS Vulnerability Disclosure link removed as part of revision 3.3.3.SummaryDifference0.4%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not all pertain to the study. The revision version has been updated to v3.3.2.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the banner about government funding lapses and potential delays in updates; the page's study details remain unchanged.SummaryDifference0.4%

- Check68 days agoChange DetectedNo significant changes were detected between the two screenshots; the page content and data appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check97 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check104 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.